Dharamshila Narayana Superspeciality Hospital

Patient Helpline 186-0208-0208

International Patient +91-9899414150

Mail Us contact@dhrc.in

Text Size

Highlights of the PET CT

Unique Technical Features

  • Latest Generation PET.CT with ultrafast LSO Crystal Technology.
  • Scans entire body and provides fused images of the PET and CT (Anatometabolic Imaging).
  • World’s Best PET resolution (2mm) for detection of smallest tumors.
  • Accurate SUV (System Uptake Value) quantification and full HD lesion detection with motion-frozen images.
  • High performance Spiral CT scanner with HRCT, 3D CT, CT Angiography, Dental C.T and CT Endoscopy.

Clinical Benefits

  • Helps in early detection and accurate staging of cancer.
  • Helps to take accurate guided biopsy samples from the suspected cancer lesions and relapsed lesions.
  • Helps in early evaluation of response to therapy.
  • Helps in accurate analysis of cancer treatment and follow up.
  • Helps in early diagnosis of Dementias and Epilepsies.

Patient’s Comfort and Safety

  • Provides enhanced Patient Comfort with high speed acquisition and lower retake exams due to improved image quality.
  • No claustrophobia because of wide gantry aperture and slim table.
  • Provides enhanced Patient safety with fully automated real-time dose modulation. Upto 65% dose reduction with full diagnostic image quality.

PET CT indications

  • Staging of cancer which potentially can be treated radically e.g. small cell lung cancer
  • Establish baseline staging before commencing treatment e.g. GIST
  • Evaluation of an indeterminate lesion e.g. solitary lung nodule
  • Assessing response to therapy
  • Evaluation of suspected disease recurrence / relapse / residual disease e.g. lymphoma, testicular seminoma
  • To guide biopsy e.g. pleural biopsy for mesothelioma

PET CT as an Aid

  • Occult primary lesion e.g. non-metastatic manifestation of neoplastic disease.
  • Evaluation of suspected recurrence in patients with equivocal conventional imaging
  • Evaluation of residual disease with negative/ equivocal conventional imaging - in patients with treated differentiated thyroid carcinoma and treated medullary thyroid carcinoma.
  • Prior knowledge to radical nodal resection - in patients with metastatic melanoma.
  • Suspected malignant transformation - in plexiform neurofibromata (type 1 neurofibromatosis)
  • Differentiate between radiation-induced necrosis and tumor recurrence e.g. brain tumors
  • PUO (Pyrexia of unknown origin) for more than three weeks to aid in identification on disease origin.

Post Your Query

Call 186-0208-0208
Mon–Sat 9:00 AM to 6:00 PM IST
Quicklinks